Metraipolis › archive › dc_93ebcafaaf12

Three-Dimensionally Printed Paediatric Medicines: Formulation, Process, and Regulatory Considerations — Europe PMC PMID:41599110

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41599110
DOI
10.3390/pharmaceutics18010002
License (as archived)
solo-consultazione
Archived
2026-11-07T12:47:52.763Z
SHA-256 of the archived text
563310fda3dd70282c18683d2d8bfff9c6cf24a7f911d653c344fe0e1a2a0420
Stable URL of this page
https://metraipolis.com/documento/dc_93ebcafaaf12

How to cite

Three-Dimensionally Printed Paediatric Medicines: Formulation, Process, and Regulatory Considerations — Europe PMC PMID:41599110 — Europe PMC (en), https://europepmc.org/article/MED/41599110 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_93ebcafaaf12 (Metraipolis archive dc_93ebcafaaf12, sha256 563310fda3dd70282c18683d2d8bfff9c6cf24a7f911d653c344fe0e1a2a0420)
BibTeX
@misc{dc93ebcafaaf12,
  title = {Three-Dimensionally Printed Paediatric Medicines: Formulation, Process, and Regulatory Considerations — Europe PMC PMID:41599110},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41599110},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_93ebcafaaf12; sha256 563310fda3dd70282c18683d2d8bfff9c6cf24a7f911d653c344fe0e1a2a0420},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41599110. Agents can read the archived copy with the MCP tool read_document.